Genetic Testing Company 23andMe Going Public At $3.5 Billion Valuation, Focus On More Therapeutics
While personal genetic testing as entertainment slowed as a revenue source in recent years, 23andMe has doubled down on its therapeutic programs.
Yes, It Is Worth Making A Federal Case Over Angelina Jolie’s Boobs
Angelina Jolie took action to address her cancer risk. If the Supreme Court gets its act together, more women can follow her example.
How LexisNexis State Net Uses Gen AI To Tame Gov’t Data
Its new features transform how you can track and analyze the more than 200,000 bills, regulations, and other measures set to be introduced this year.